MOC News and Press, Command Security Corporation From 06/23/23

OATD-01 is a first in class chitotriosidase 1 (CHIT1) inhibitor with disease modifying potential in sarcoidosis and other interstitial lung diseases Clearance of the IND application will pave the way for Molecure to initiate the study in the United States becoming only the second Polish b...

MONTREAL, June 07, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) announces that it has delayed all exploration activities at its James Bay lithium projects following an emergency fire evacuation order from the Ministry ...

MONTREAL, May 23, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) is pleased to announce that it has counted the presence of 52 pegmatites favorable to the presence of lithium on its Mirabelli SM project , located less th...

MONTREAL, April 25, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) has obtained a first interim report identifying several pegmatites containing lithium showings as well as a set of potential unanalyzed pegmatites or vis...

MONTREAL, April 11, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) announces that it intersected in hole GA-23-13 a section of 159.5 meters grading 0.23% Ni including 96.5 meters grading 0.25% Ni and 51 meters grading 0....

MONTREAL, April 04, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) would first like to congratulate the management of Patriot Battery Metals for the success it is achieving in the development of its Corvette project ...

Molecure Announces Full Year Financial 2022 Results – A Year of Significant Progress Entering 2023 with strong momentum and a robust pipeline of proprietary, first-in-class compounds First patient dosed in Phase I trial with OATD-02, a novel, first in class dual arginase ...

Molecure announces first patient dosed in Phase I trial with n ovel , first - in - class dual arginase inhibitor O ATD-02 for the treatment of cancer OATD-02 is an oral, potent and selective dual arginase inhibitor (ARG...

MONTREAL, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company ” ) is pleased to report that 3,046,000 common share purchase warrants, with an exercise price of $0.10 issued on August 20, 2021, have now been exercis...

MONTREAL, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company ”). After several acquisitions, Mosaic summarizes its portfolio of properties focused on lithium exploration located mainly in James Bay (Quebec). All...